“Prospects of using the genetically engineered preparation dupilumab for the treatment of atopic dermatitis in the adult population”, J Pak Assoc Dermatol, vol. 32, no. 2, pp. 327–333, Jun. 2022, doi: 10.66344/jpad.v32i2.1900.